The time-varying effect of radiotherapy after breast-conserving surgery for DCIS

Breast Cancer Research and Treatment
Eileen RakovitchLawrence Paszat

Abstract

A better understanding underlying radiation (RT) response after breast-conserving surgery (BCS) is needed to mitigate over-treatment of DCIS. The hazard ratio (HR) measures the effect of RT but assumes the effect is constant over time. We examined the hazard function adjusted for adherence to surveillance mammography to examine variations in LR risk and the effect of RT over time. Crude hazard estimates for the development of LR in a population cohort of DCIS treated by BCS ± RT were computed. Multivariable extended Cox models and hazard plots were used to examine the association between receipt of RT and risk of each outcome adjusted for baseline covariates and adherence to mammography. Population cohort includes 3262 women treated by BCS; 1635 received RT. Median follow-up was 13 years. LR developed in 364 women treated by BCS alone and 274 treated with RT. LR risk peaked at 2 years, declined until year 7, and then remained steady. The peak hazard of LR was associated with adverse features of DCIS. Early LR risk was attenuated in patients treated with RT but late annual risks of LR and invasive LR were similar among the two treatment groups. On multivariate analysis, RT was associated with a reduction in early LR risk (HR = 0...Continue Reading

References

Jan 23, 1999·Journal of the American College of Surgeons·A RatanawichitrasinJ P Crowe
Jan 3, 2006·Journal of Theoretical Biology·Heiko EnderlingJayant S Vaidya
Oct 3, 2008·Breast Cancer Research and Treatment·James J DignamNorman Wolmark
May 12, 2010·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Wei-wei Liu, Liang-ping Hu
Oct 20, 2010·Journal of the National Cancer Institute. Monographs·C CorreaS Darby
Mar 20, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lee ChengSharon H Giordano
Mar 5, 2013·Breast Cancer Research and Treatment·Eileen RakovitchLawrence Paszat
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mila DonkerNina Bijker
Oct 15, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fredrik WärnbergLars Holmberg
Sep 1, 2015·BMJ : British Medical Journal·Philip Sedgwick, Katherine Joekes
Feb 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yasuaki SagaraMehra Golshan
Apr 1, 2017·Journal of the National Cancer Institute·Eileen RakovitchLawrence Paszat
Jul 29, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Troy BremerFredrik Wärnberg
Nov 19, 2018·Breast Cancer Research and Treatment·Brian L SpragueDonald L Weaver

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.